CERAMIC FIBER PRODUCTS

MATERIAL SAFETY DATA SHEET(MSDS)

Date: Jan 01 2013

1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

Product Group: REFRACTORY CERAMIC FIBER PRODUCT
Chemical Name: VITREOUS ALUMINOSILICATE FIBER
Synonyms: RCF, ceramic fiber, synthetic vitreous fiber (SVF),
man-made vitreous fiber (MMVF), man-made mineral fiber (MMMF)
Trade Names: CCEWOOL®, PUREWOOL™
Blanket,Board,Paper, Modules, Strips, Bulk, Engineered Fiber (all grades)
CAS Number: 142844-00-6
Manufacturer/Supplier:
Zibo Double Egret Thermal Insulation Co.,Ltd.
South of Shangzhuang Sibaoshan Town Zibo Development Zone Shandong China

2. COMPOSITION / INFORMATION ON INGREDIENTS

COMPONENTS
Refractories, Fibers, Aluminosilicate
3. HAZARDS IDENTIFICATION
HAZARD PICTOGRAM

SINGAL WORD: Danger

EMERGENCY OVERVIEW
WARNING!
POSSIBLE CANCER HAZARD BY INHALATION.
CHRONIC EFFECT
There has been no increased incidence of respiratory disease in studies examining occupationally
exposed workers. In
animal studies, long term laboratory exposure to doses hundreds of times higher than normal
occupational exposures
has produced fibrosis, lung cancer and mesothelioma in rats or hamsters. The fibers used in those
studies were
specially sized to maximize rodent respirability.
OTHER POTENTIAL EFFECTS
TARGET ORGANS:
Respiratory Tract (nose and throat), Eyes, Skin
RESPIRATORY TRACT (nose and throat) IRRITATION:
If inhaled in sufficient quantity, may cause temporary, mild mechanical irritation to respiratory tract.
Symptoms may include
scratchiness of the nose or throat, cough or chest discomfort.
EYE IRRITATION:
May cause temporary, mild mechanical irritation. Fibers may be abrasive; prolonged contact may cause
damage to the outer
surface of the eye.

SKIN IRRITATION:
May cause temporary, mild mechanical irritation. Exposure may also result in inflammation, rash or itching.
GASTROINTESTINAL IRRITATION:
Unlikely route of exposure.
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE:
Pre-existing medical conditions, including dermatitis, asthma or chronic lung disease may be aggravated by
exposure;
individuals who have a history of allergies may experience greater amounts of skin and respiratory irritation.
Although studies, involving occupationally exposed workers, have not identified any increased
incidence of respiratory disease, results from animal testing have been used as the basis for
hazard classification. In each of the following cases, the conclusions are qualitative only and do
not rest upon any quantitative analysis suggesting that the hazard actually may occur at current
occupational exposure levels.

4. FIRST AID MEASURES

RESPIRATORY TRACT (nose and throat) IRRITATION:
If respiratory tract irritation develops, move the person to a dust free location. See Section 8 for
additional measures to
reduce or eliminate exposure.
EYE IRRITATION:
If eyes become irritated, flush immediately with large amounts of lukewarm water for at least 15
minutes. Eyelids
should be held away from the eyeball to ensure thorough rinsing. Do not rub eyes.
GASTROINTESTINAL IRRITATION:
If gastrointestinal tract irritation develops, move the person to a dust free environment.
NOTES TO PHYSICIANS:
Skin and respiratory effects are the result of temporary, mild mechanical irritation; fiber exposure
does not result in allergic manifestations.

5. HANDLING AND STORAGE

STORAGE
Store in original container in a dry area. Keep container closed when not in use.
HANDLING
Handle ceramic fiber carefully. Limit use of power tools unless in conjunction with local exhaust.
Use hand tools whenever possible. Frequently clean the work area with HEPA filtered vacuum or
wet sweeping to minimize the accumulation of debris. Do not use compressed air for clean-up.

EMPTY CONTAINERS
Product packaging with plastic & carton.not effect container.

6. DISPOSAL CONSIDERATIONS
WASTE MANAGEMENT
To prevent waste materials from becoming airborne during waste storage, transportation and
disposal, a covered container or plastic bagging is recommended.

7. ECOLOGICAL INFORMATION
No ecological concerns have been identified.

8. TOXICOLOGICAL INFORMATION
HEALTH DATA SUMMARY
Epidemiological studies of RCF production workers have indicated no increased incidence
of respiratory disease nor other significant health effects. In animal studies, long-term,
high-dose inhalation exposure resulted in the development of respiratory disease in rats
and hamsters.

EPIDEMIOLOGY
The University of Cincinnati is conducting an ongoing epidemiologic investigation. The evidence
obtained from employees in U. S. RCF manufacturing facilities is as follows:
1) There is no evidence of any fibrotic lung disease (interstitial fibrosis) from evaluations of chest
X-rays.
2) There is no evidence of an elevated incidence of lung disease among RCF manufacturing
employees.
3) In early studies, an apparent statistical “trend” was observed, in the exposed population,
between RCF exposure duration and some measures of lung function. The observations were
clinically insignificant. If these observations were made on an individual employee, the results
would be interpreted as being within the normal (predicted) respiratory range. A more recent
longitudinal study of employees with 5 or more pulmonary function tests found that there was no
effect on lung function associated with RCF production experience. Initial data (circa 1987)
seemed to indicate an interactive effect between smoking and RCF exposure; more recent data,
however, found no interactive effect. Nevertheless, to promote good health, RCF employees are
still actively encouraged not to smoke.
4) Pleural plaques (thickening along the chest wall) have been observed in a small number of RCF
employees. Some studies appear to show a relationship between the occurrence of pleural
plaques on chest radiographs and the following variables: (a) years since RCF production hire
date; (b) duration of RCF production employment; and (c) cumulative RCF exposure. The best
evidence to date indicates that pleural plaques are a marker of exposure only. Pleural plaques are
not associated with pulmonary impairment. The pathogenesis of pleural plaques remains
incompletely understood; however, the mechanism appears to be an inflammatory response
caused by inhaled fibers.

TOXICOLOGY
A number of toxicological studies designed to identify any potential health effects from RCF
exposure have been completed. In one study, conducted by the Research and Consulting
Company, (Geneva, Switzerland), rats and hamsters were exposed to 30 mg/m³ (about 200
fibers/cc) of specially-prepared RCF for 6 hours/day, 5 days/week, for up to 24 months. In rats, a
statistically significant increase in lung tumors was observed; two mesotheliomas (cancer of the
pleural lining between the chest wall and lung) were also identified. Hamsters did not develop lung
tumors; however, interstitial fibrosis and mesothelioma was found. Some, in the scientific
community, have concluded that the “maximum tolerated dose” was exceeded and that significant
particle contamination was a confounding issue; therefore, these study findings may not represent
an accurate assessment of the potential for RCF to produce adverse health effects.
In a related multi-dose study with a similar protocol, other rats were exposed to doses of 16 mg/m³,
9 mg/m³, 3 mg/m³ which corresponds to about 115, 75, and 25 fibers per cubic centimeter
respectively. This study found no statistically significant increase in lung cancer. Some cases of
pleural and parenchymal fibrosis were seen in the 16 mg/m³ dose group. Some cases of mild
fibrosis and one mesothelioma were observed in the 9 mg/m³ group. No acute respiratory effects
were seen in the rats in the 3 mg/m³ exposure group, which suggests that there may be a
dose/response threshold, below which irreversible respiratory impacts do not occur.
Other toxicological studies have been conducted which utilized non-physiological exposure
methods such as intrapleural, intraperitoneal and intratracheal implantation or injection. Some of
these studies have found that RCF is a potential carcinogen. Some experts, however, suggest that
these tests have limited relevance because they bypass many of the biological mechanisms that
prevent fiber deposition or facilitate fiber clearance.

9. PHYSICAL AND CHEMICAL PROPERTIES

ODOR AND APPEARANCE: White, odorless, fibrous material

CHEMICAL FAMILY: Vitreous Aluminosilicate Fibers
BOILING POINT: Not Applicable
WATER SOLUBILITY (%): Not Soluble in Water
MELTING POINT: 1760° C (3200° F)
SPECIFIC GRAVITY: 2.50 – 2.75
VAPOR PRESSURE: Not Applicable
pH: Not Applicable
VAPOR DENSITY (Air = 1): Not Applicable
% VOLATILE: Not Applicable
MOLECULAR FORMULA: Not Applicable

10. STABILITY AND REACTIVITY

CHEMICAL STABILITY: Stable under conditions of normal use.
INCOMPATIBILITY: Soluble in hydrofluoric acid, phosphoric acid, and concentrated alkali.
CONDITIONS TO AVOID: None.
HAZARDOUS DECOMPOSITION PRODUCTS: None.
HAZARDOUS POLYMERIZATION: N/A

11. ECOLOGICAL INFORMATION

No ecological concerns have been identified

12. WASTE DISPOSAL

Approved landfill. This substance is not specifically listed as hazardous waste in federal
regulations. For particular situation
check Federal definition 40 CFR 261 and State regulations. Check local, regional, state or
provincial regulations to identify all
applicable disposal requirements.
N/D: No Data N/A: Not Applicable

13. OTHER ADVERSE EFFECTS

No additional information available

14. TRANSPORT INFORMATION

UN number
Not Applicable
UN proper shipping name
Not Applicable
Transport hazard class(es)
Not Applicable
Packing group
Not Applicable
Environmental hazards
Not Applicable
Special precautions for user
Not Applicable
Transport in bulk according to Annex II of MARPOL73/78 and the IBC Code
Not Applicable

15. REGULATORY INFORMATION

SAFETY, HEALTH AND ENVIRONMENT REGULATIONS/LEGISLATION SPECIFIC FOR THE

SUBSTANCES OR MIXTURES
EU regulations:

• Regulation (EC) No 1907/2006 dated 18th December 2006 on Registration,

Evaluation, Authorization and Restriction of Chemicals (REACH)
• Regulation (EC) No 1272/2008 dated 20th January 2009 on classification, labelling
and packaging of substances and mixtures (OJ L 353).
• Annex of Regulation (EU)2015/830.
• Commission regulation (EC) No 790/2009 of 10 August 2009 amending, for the
purposes of its adaptation to technical and

scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of

the Council on classification, labelling
 and packaging of substances and mixtures.

• The 1st Adaptation to Technical Progress (ATP) to Regulation (EC) No 1272/2008

enters into force on 25 September 2009.

Integration of RCF/ASW in to ANNEXE XV of the REACH Regulation:

RCF are classified as a carcinogenic substance CLP 1B (See section 15 above). On

the 13th of January 2010, ECHA updated the candidate list for authorization (annexes
XV of the REACH regulation) and added 14 new substances in this list including
aluminosilicate refractory ceramic fibres and zirconia aluminosilicate refractory
ceramic fibres.
As a consequence, EU (European Union) or EEA (European Economical Area)
suppliers of articles which contain aluminosilicate refractory ceramic fibres and
zirconia aluminosilicate refractory ceramic fibres in a concentration above 0.1% (w/w)
have to provide sufficient information, available to them, to their customers or upon
requests to a consumer within 45 days of the receipt of the request. This information
must ensure safe use of the article and as minimum contains the name of the
substance.

Restriction on Marketing of RCF/ASW

Marketing and use of RCF/ASW is controlled by Directive 76/769/EEC relating to

restrictions on the marketing and use of certain dangerous substances and
preparations as modified (21st amending, Directive 2001/41/EC, 19 June 2001) and
is restricted to professional use only.

CHEMICAL SAFETYASSESSMENTV

A Chemical Safety Assessment has been carried out for RCF/ASW and CSR can be provided
on request

16. OTHER INFORMATION

USEFUL REFERENCES (the directives which are cited must be considered in their amended
version)

• Hazards from the use of Refractory Ceramic Fibre. Health and Safety Executive:
Information document, HSE 267

(1998).

• Working with High Temperature Insulation wools 2006;

• ECFIA; Code of Practice.
• Maxim LD et al (1998). CARE – A European programme for monitoring and reducing
Refractory Ceramic Fibre

dust at the workplace initial results; Gefahrstoffe – Reinhaltung der Luft, 58:3,97-103.

• Recognition and control of exposure to RCF, ECFIA, April 2009

•
• PRECAUTIONARY MEASURES
Additional information and precautions to be considered upon removal of after
service material
As produced, all Refractory Ceramic Fibres are vitreous (glassy) materials which,
upon continued exposure to elevated temperatures (above 900°C), may devitrify. The
occurrence and extent of crystalline phase formation is dependent on the duration
and temperature of exposure, fibre chemistry and/or the presence of fluxing agents.
The presence of crystalline phases can be confirmed only through laboratory analysis
of the "hot-face" fibre.
IARC’s evaluation of crystalline silica states "Crystalline silica inhaled in the form of
quartz or cristobalite from occupational sources is carcinogenic to humans (Group 1)"
and additionally mentioned, "in making the overall evaluation, the Working Group
noted that carcinogenicity in humans was not detected in all industrial circumstances
studied..."
As only, a thin layer of the insulation (hot face side) is exposed to high temperatures,
respirable dust generated during removal operations does not contain detectable
levels of crystalline silica (CS).
In applications where the material is heat soaked, duration of heat exposure is
normally short and a significant devitrification allowing CS to build up does not occur.
This is the case for waste mould casting for instance.
Toxicological evaluation of the effect of the presence of CS in artificially heated
RCF/ASW material has not shown any increased toxicity in vitro.
The lack of toxicological effects may be explained by the following factors;
Increased brittleness of fibres after service life, favours fast fibre translocation through
macrophage. Micro crystals, including crystalline silica, are embedded in the glass
structure of the fibre and are therefore not biologically available.
The IARC evaluation as provided in Monograph 68 is not relevant as CS is not
biologically available in after- service RCF/ASW.
High concentrations of fibres and other dusts may be generated when after-service
products are mechanically disturbed during operations such as wrecking. Therefore
ECFIA recommends:
• a) control measures are taken to reduce dust emissions;
• b) all personnel directly involved wear an appropriate respirator to minimise
exposure; and
• c) Compliance with local regulatory limits.
 •
• SDS No. DE0001EU Rev 3
Date of Last Revision: APR/05/2020
•

NOTICE:
The information presented here in is based on data considered to be accurate as of the date of
preparation of this Safety Data Sheet. However, no warranty or representation, express or implied,
is made as to the accuracy or completeness of the foregoing data and safety information, nor is
any authorisation given or implied to practice any patented invention without a licence. In addition,
no responsibility can be assumed by the vendor for any damage or injury resulting from abnormal
use, from any failure to adhere to recommended practices, or from any hazards inherent in the
nature of the product.